Horizon Therapeutics Raises $15M
Palo Alto-based Horizon Therapeutics said today that it has raised $15M in a Series B financing, led by Scale Venture Partners. Horizon, which is developing non-steroidal, anti-inflammatory ibuprofen. The round also included Sutter Hill Ventures and Pequot Ventures. Horizon also disclosed a Series A round worth $6M in October of 2005 from the same investors.
posted on Thursday, January 4, 2007 (Link to more information)
Related companies:
Horizon
Related stories:
> Performance Horizon Gets $15.4M
> Arete Therapeutics Raises $35M
> Nuon Therapeutics Raises $27M
> Lead Therapeutics Raises $17M
> Emerald Therapeutics Raises $13.5M For Robotic Wet Labs
silicontap.com Home